Matthew P. Cheng @cfDNAlex We are all very proud. Well done Alex!

If 100,000 people retweet this my girlfriend said we can get a French Bull Dog and name it Pickle. This is not a drill.

This is the best explanation of the Covid Vaccine I’ve ever heard.

Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock. Do you support this?

For my peers who are leaving academia starting 2022, and who are happy about their decision and thriving: ☀️ I am so, so happy and proud for you. You deserve nothing but the best. ❤️ But also, I will miss you, very much, more than you can ever imagine.

Thrilled to see this work on #cfDNA in #HCT patients come out in PNASNews Alexandre Pellan Cheng you did a fantastic job leading this effort. Francisco Marty, MD I hope we did you proud. pnas.org/content/119/4/…

Kanvas is excited to announce a series of new job postings! We’re looking to bring in people who are passionate about biotech and looking to make a transformative impact through microbiome analysis! Please see the attached postings.

"Why do so few scientists make significant contributions and so many are forgotten in the long run?" Mathematician and computer scientist Richard Hamming sought the answer to this question later in his career. He had been lucky enough to work on "the right problems" (his work

Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent immune response against a distant tumor. Y. Erin Chen, MD PhD led the charge w/ help from Djenet Bousbaine, Alessandra Veinbachs, Belkaid Lab. Science Magazine 1/26 science.org/doi/10.1126/sc…

How do we know who is where in a mixed microbial community? Metagenomics tells us who, but it doesn't give us spatial info. Enter HiPR-FISH! 🎉🧀🔬 Check out our pub (arcadia-research.pubpub.org/pub/data-set-h…) describing our application of HiPR-FISH to cheese microbiomes Arcadia Science 🧵[1/5]

We're excited to announce the funding of our Pre-Series A round, led by DCVC ! With the additional funding, we will expand our platform to revolutionize the field of microbiome therapeutics. prnewswire.com/news-releases/…

I have exciting news to share - kanvasbio founded by Hao Shi, Matthew P. Cheng and me, has secured pre-series A funding. Congrats to the brilliant team at Kanvas, and huge thanks to our investors, mentors, friends and supporters! @dcvc Cornell BME prnewswire.com/news-releases/…

Princeton, NJ-based microbiome mapping technology kanvasbio raised $12M pre-Series A led by DCVC. Proprietary single-cell spatial transcriptomics platform. CEO/co-founder is microbiologist & ID doc Matthew P. Cheng. Board director Jason Pontin wrote: dcvc.com/post/dcvc-lead…

A nice summary of our company and field from Jason Pontin and DCVC . We're excited to chart new territory with them! dcvc.com/post/dcvc-lead…

.DCVC-backed kanvasbio has just gained strength in its work to bring better microbiome therapies to market. More from DCVC General Partner Jason Pontin. 👇 bit.ly/48I9YOd

DCVC portfolio Kanvas Biosciences (kanvasbio), which has pioneered a spatial biology platform that can profile host-microbiome interactions, announces that it has acquired Federation Bio's assets to become a clinical-stage drug company. My article here: dcvc.com/news-insights/…

We are thrilled to share that our website has officially launched! It was a ton of fun collaborating with One Design Company to create a site that truly captures the groundbreaking science Kanvas works to develop. Check us out at kanvasbio.com

What a brilliant Science Day 2023! We are so grateful for the team, partners, and investors who made it all possible and we look forward to Kanvas Bio's 2024 development and discoveries. Read about Science Day 2023 here: kanvasbio.com/news/kanvas-ct…